Author:
Romanowski Kamila,Chiang Leslie Y.,Roth David Z.,Krajden Mel,Tang Patrick,Cook Victoria J.,Johnston James C.
Publisher
Springer Science and Business Media LLC
Reference21 articles.
1. World Health Organization. Global tuberculosis report 2016. [Internet]. Available from:
http://www.who.int/tb/publications/global_report/en/
. Accessed 13 Oct 2016.
2. Jindani A, Aber VR, Edwards EA, Mitchison DA. The Early Bactericidal Activity of Drugs in Patients with Pulmonary Tuberculosis 1, 2. Am Rev Respir Dis. 1980;121:939–49.
3. Sirgel FA, Donald PR, Odhiambo J, Githui W, Umapathy KC, Paramasivan CN, et al. A multicentre study of the early bactericidal activity of anti-tuberculosis drugs. J Antimicrob Chemother. 2000;45:859–70.
4. Jenkins HE, Zignol M, Cohen T. Quantifying the Burden and Trends of Isoniazid Resistant Tuberculosis, 1994–2009. PLoS One. 2011;6:e22927.
5. Menzies D, Benedetti A, Paydar A, Martin I, Royce S, Pai M, et al. Effect of duration and intermittency of rifampin on tuberculosis treatment outcomes: a systematic review and meta-analysis. PLoS Med. 2009;6:e1000146.
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献